Due Diligence Capabilities
Have confidence when preparing to enter into a potential legal agreement in the life sciences industry with deep experts who can help you assess the situation thoroughly.
We offer a synthesis of strategic insight, experience, and a fact-based approach combined with our exposure to clients across the pharmaceutical, biotech, and device landscapes.Start Getting More Done!
Deep Industry Experience
Kymanox does life sciences. Period. And that means you get well-rounded industry experts who will help you accurately understand the situation.Start Getting More Done!
Good, Old-Fashioned Honesty
If you’re looking for a real honest analysis and recommendation and are willing to hear news that may contradict your intentions Kymanox is excited to partner with you on your project.Start Getting More Done!
Not too big, not too small
Kymanox is a fast-growing company devoted to the life sciences industry. Our 100+ employees means we have a plethora of experience to leverage on your project but you won’t get lost in the shuffle found at larger firms.Start Getting More Done!
Meet our Due Diligence Experts
Stephen M. Perry
Markets That Benefit from Our Due Diligence Solutions
Our experts understand the interaction between devices and drug products. Our experience includes injectables, nasal, respiratory, and more.
Biologics & Cell and Gene Therapy Services
We understand why “the product is the process” and how to implement solutions to your unique challenges.
Drug development is constantly evolving with new regulations and technology. We stay up to date to maintain your compliance.
The Kymanox Due Diligence Difference
Our clients tell us traditional integrators simply do not fully understand the complexities of working in a highly regulated environment. The Kymanox team lives in regulatory environments every day so you’ll get practical solutions.
Proven Broad Expertise
Our team of experts is focused on life sciences with extensive experience across drug and device development. No matter your challenge, we can help you conquer it.
Flexibility & Agility
At Kymanox, we make it easy for clients to get the solutions they need, when they need it. Clients tell us our flexibility is one of the key reasons they keep coming back.
We are proud of the relationships we build with our clients. Many times, we are indistinguishable from client employees on projects. It’s one reason our first client, and many others, are still clients today.
Frequently Asked Due Dilligence Questions (FAQs)
What is due diligence?
Due diligence is an investigation, audit, or review performed to confirm facts or details of a matter under consideration. In the financial world, due diligence requires an examination of financial records before entering into a proposed transaction with another party. (Source: investopedia.com)
What does due diligence typically cover?
Information should cover all aspects of a business and typically cover most, if not all, of the following categories. Please note this list is not exhaustive but is designed to provide perspective on the breadth of information involved.
- Company information including structure, ownership details, competitors, suppliers, recent annual reports
- Financial information including balance sheets, income statements, tax returns, and credit reports.
- Product & Service offering which includes details on all items the company sells along with associated specific details on costs, margins, historical sales, and forecast. Included with this should be any details on new products/services that are in development.
- Customer information including prior sales by customer in addition to names of companies and contact information, where applicable.
- Employee & freelancer/contractor information
- Intellectual property including patents, copyrights, trademarks, etc.
- Legal landscape including applicable laws and regulations, prior litigation, applicable permitting/licensing, and insurance policies.
Read the Latest at Kymanox
Kymanox Acquires Agilis Consulting Group, A Trusted Human Factors Provider
Kymanox Acquires Agilis Consulting Group, A Trusted Human Factors Provider Integrating the well-respected and trusted Agilis brand and team extends Kymanox’s capabilities in human factors (HF) by adding incredible talent, the ability to conduct HF stu...
Investment Reports Interview with Stephen M. Perry, CEO and Founder of Kymanox
Kymanox CEO and Founder, Stephen M. Perry was interviewed as part of the Investment Reports article, The New Era of Life Sciences 2023, published on 17MAR23, What were the circumstances that brought Kymanox to life and what does your present foo...
Kymanox Acquires EU Based Anteris Medical and Anteris Helvetia
Leveraging the well-respected anteris brand and team, this acquisition extends Kymanox’s capabilities and geographic reach with a strong European presence Friday, 03 February 2023 Morrisville, North Carolina, USA and Holzkirchen, Germany an...